SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences Group Market Cap : 800.94M for April 24, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Spero Therapeutics, Inc. | 158.62M |
| Recursion Pharmaceuticals, Inc. | 1.854B |
| ACADIA Pharmaceuticals, Inc. | 3.744B |
| Alnylam Pharmaceuticals, Inc. | 40.52B |
| Savara, Inc. | 1.048B |
Market Cap Related Metrics
| Price to Book Value | 11.30 |
| Price | 4.46 |
| Earnings Yield | -5.51% |